Plante Moran Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Plante Moran Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45	Closed	-$7.17K	–	845
2022 Q4	$7.17K	Buy	+45	New	+$6.59K	﹤0.01%	622
2022 Q3	–	Sell	-13	Closed	-$2K	–	963
2022 Q2	$2K	Buy	+13	New	+$2K	﹤0.01%	819
2022 Q1	–	Sell	-134	Closed	-$17K	–	902
2021 Q4	$17K	Buy	+134	New	+$17.6K	﹤0.01%	593
2014 Q4	–	Sell	-200	Closed	-$32K	–	827
2014 Q3	$32K	Buy	+200	New	+$30.7K	0.03%	324

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Plante Moran Financial Advisors's JAZZ Position: Q1 2023 in Review

Plante Moran Financial Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2023, closing a stake of 45 shares — an estimated $7.17K sold.

Plante Moran Financial Advisors first reported a position in JAZZ in Q3 2014 and held it in 4 quarters. The position peaked at $32K in Q3 2014. 471 funds tracked by Wall St. Rank hold JAZZ as of Q1 2023.

Plante Moran Financial Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Plante Moran Financial Advisors sold 45 Jazz Pharmaceuticals shares in Q1 2023, an estimated $7.17K.
Plante Moran Financial Advisors first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 4 quarters.
Plante Moran Financial Advisors's Jazz Pharmaceuticals position peaked at $32K in Q3 2014.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2023.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2023, filed 8 May 2023.